LPM-3480392

N/A

Report date: 2022/09/19 20:00:41
NME

Base Information

Drug NameLPM-3480392
Drug Alias NameLPM-3480392LY03014LY-03014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsCancer PainBreakthrough PainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLuye Pharma Group LtdShandong Luye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCancer PainBreakthrough PainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A